These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8447439)

  • 21. Characterization of human peripheral blood monocyte thromboxane A2 receptors.
    Allan CJ; Halushka PV
    J Pharmacol Exp Ther; 1994 Aug; 270(2):446-52. PubMed ID: 8071836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth factors downregulate vascular smooth muscle thromboxane receptors independent of cell growth.
    Dorn GW; Becker MW
    Am J Physiol; 1992 Apr; 262(4 Pt 1):C927-33. PubMed ID: 1533095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tissue- and species-specific differences in ligand binding to thromboxane A2 receptors.
    Dorn GW
    Am J Physiol; 1991 Jul; 261(1 Pt 2):R145-53. PubMed ID: 1830459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TXA2 agonists inhibit high-voltage-activated calcium channels in rat hippocampal CA1 neurons.
    Hsu KS; Huang CC; Kan WM; Gean PW
    Am J Physiol; 1996 Oct; 271(4 Pt 1):C1269-77. PubMed ID: 8897834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific receptors for thromboxane A2 in cultured vascular smooth muscle cells of rat aorta.
    Hanasaki K; Nakano K; Kasai H; Arita H; Ohtani K; Doteuchi M
    Biochem Biophys Res Commun; 1988 Feb; 150(3):1170-5. PubMed ID: 2963633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thromboxane A2 (TP) receptor in the non-pregnant porcine myometrium and its role in regulation of spontaneous contractile activity.
    Cao J; Wakatsuki A; Yoshida M; Kitazawa T; Taneike T
    Eur J Pharmacol; 2004 Feb; 485(1-3):317-27. PubMed ID: 14757156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological characterization of potent, long-acting thromboxane receptor antagonists, SQ 33,261 and SQ 33,552.
    Harris DN; Michel IM; Goldenberg HJ; Hartl KS; Allen GT; Steinbacher TE; Schumacher WA; Han WC; Hall SE; Floyd DM
    J Pharmacol Exp Ther; 1992 Apr; 261(1):131-7. PubMed ID: 1532833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glomerular thromboxane A2/prostaglandin H2 receptors: characterization and effect of adriamycin-induced nephrotic syndrome.
    Mayeux PR; Shah SV
    Biochim Biophys Acta; 1993 Apr; 1181(2):148-54. PubMed ID: 8481403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thromboxane receptors in human kidney tissues.
    Brown GP; Venuto RC
    Prostaglandins Other Lipid Mediat; 1999 Jun; 57(4):179-88. PubMed ID: 10402213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thromboxane A2 induces cell signaling but requires platelet-derived growth factor to act as a mitogen.
    Grosser T; Zucker TP; Weber AA; Schulte K; Sachinidis A; Vetter H; Schrör K
    Eur J Pharmacol; 1997 Jan; 319(2-3):327-32. PubMed ID: 9042608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct platelet thromboxane A2/prostaglandin H2 receptor subtypes. A radioligand binding study of human platelets.
    Dorn GW
    J Clin Invest; 1989 Dec; 84(6):1883-91. PubMed ID: 2531760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human platelet aggregation and shape change are coupled to separate thromboxane A2-prostaglandin H2 receptors.
    Dorn GW; DeJesus A
    Am J Physiol; 1991 Feb; 260(2 Pt 2):H327-34. PubMed ID: 1825455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Androgen regulation of thromboxane A2/prostaglandin H2 receptor expression in human erythroleukemia cells.
    Matsuda K; Mathur RS; Duzic E; Halushka PV
    Am J Physiol; 1993 Dec; 265(6 Pt 1):E928-34. PubMed ID: 8279549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclic oxidation-reduction reactions regulate thromboxane A2/prostaglandin H2 receptor number and affinity in human platelet membranes.
    Dorn GW
    J Biol Chem; 1990 Mar; 265(8):4240-6. PubMed ID: 2137820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tyrosine phosphorylation of phosphatidylinositol 3-kinase and of the thromboxane A2 (TXA2) receptor by the TXA2 mimetic I-BOP in A7r5 cells.
    Morinelli TA; Finley EL; Jaffa AA; Kurtz DT; Ullian ME
    Biochem Pharmacol; 1997 Jun; 53(12):1823-32. PubMed ID: 9256157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new family of thromboxane receptor antagonists with secondary thromboxane synthase inhibition.
    Pace-Asciak CR; Reynaud D; Demin P; Aslam R; Sun A
    J Pharmacol Exp Ther; 2002 May; 301(2):618-24. PubMed ID: 11961065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of glomerular thromboxane receptor sites in the rat.
    Wilkes BM; Solomon J; Maita M; Mento PF
    Am J Physiol; 1989 Jun; 256(6 Pt 2):F1111-6. PubMed ID: 2525345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of thromboxane A2/prostaglandin H2 binding sites in guinea pig cardiac membrane preparations.
    Bowling N; Dubé GP; Kurtz WL; Brune KA; Saussy DL; Dorn GW; Mais DE
    J Mol Cell Cardiol; 1994 Jul; 26(7):915-23. PubMed ID: 7966360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thromboxane A2 receptors are influenced by cell density in cultured rat aortic smooth muscle cells.
    Masuda A; Halushka PV
    Life Sci; 1991; 48(25):2391-5. PubMed ID: 1828517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thromboxane A2 receptor signaling inhibits vascular endothelial growth factor-induced endothelial cell differentiation and migration.
    Ashton AW; Ware JA
    Circ Res; 2004 Aug; 95(4):372-9. PubMed ID: 15242977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.